Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
15001
15002
15003
15004
15005
15006
15007
15008
15009
15010
15011
15012
15013
15014
15015
15016
15017
15018
15019
15020
15021
15022
15023
15024
15025
15026
15027
15028
15029
15030
15031
15032
15033
15034
15035
15036
15037
15038
15039
15040
15041
15042
15043
15044
15045
15046
15047
15048
15049
15050
15051
15052
15053
15054
15055
15056
15057
15058
15059
15060
15061
15062
15063
15064
15065
15066
15067
15068
15069
15070
15071
15072
15073
15074
15075
15076
15077
15078
15079
15080
15081
15082
15083
15084
15085
15086
15087
15088
15089
15090
15091
15092
15093
15094
15095
15096
15097
15098
15099
15100
15101
15102
15103
15104
15105
15106
15107
15108
15109
15110
15111
15112
15113
15114
15115
15116
15117
15118
15119
15120
15121
15122
15123
15124
15125
15126
15127
15128
15129
15130
15131
15132
15133
15134
15135
15136
15137
15138
15139
15140
15141
15142
15143
15144
15145
15146
15147
15148
15149
15150
15151
15152
15153
15154
15155
15156
15157
15158
15159
15160
15161
15162
15163
15164
15165
15166
15167
15168
15169
15170
15171
15172
15173
15174
15175
15176
15177
15178
15179
15180
15181
15182
15183
15184
15185
15186
15187
15188
15189
15190
15191
15192
15193
15194
15195
15196
15197
15198
15199
15200
| UnnamedSample_HQ_transcript/10046|m.3846 | UnnamedSample_HQ_transcript/10046 | Identity 0.800 too low. | 590317e2f24d69fff28753f3d05231bb | 1256 | Pfam | PF11878 | Domain of unknown function (DUF3398) | 50 | 161 | 1.3E-32 | T | 22-09-2020 | IPR021816 | Dedicator of cytokinesis C/D, N-terminal |
| UnnamedSample_HQ_transcript/10046|m.3846 | UnnamedSample_HQ_transcript/10046 | Identity 0.800 too low. | 590317e2f24d69fff28753f3d05231bb | 1256 | Pfam | PF14429 | C2 domain in Dock180 and Zizimin proteins | 575 | 751 | 3.4E-49 | T | 22-09-2020 | IPR027007 | DHR-1 domain |
| UnnamedSample_HQ_transcript/19303|m.6668 | UnnamedSample_HQ_transcript/19303 | Coverage 0.696 too low. | 7491bdbaa76b7cbd10dc0833d5d940df | 845 | Pfam | PF00595 | PDZ domain | 749 | 830 | 2.2E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/8819|m.3453 | UnnamedSample_HQ_transcript/8819 | Coverage 0.762 too low. | 7491bdbaa76b7cbd10dc0833d5d940df | 845 | Pfam | PF00595 | PDZ domain | 749 | 830 | 2.2E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/83856|m.20320 | UnnamedSample_HQ_transcript/83856 | Identity 0.874 too low. | e1287324c1b31409dd86db3445a23cfa | 201 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 155 | 194 | 9.9E-7 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/103159|m.23010 | UnnamedSample_HQ_transcript/103159 | Identity 0.908 too low. | e1287324c1b31409dd86db3445a23cfa | 201 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 155 | 194 | 9.9E-7 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/101685|m.22831 | UnnamedSample_HQ_transcript/101685 | Identity 0.902 too low. | e1287324c1b31409dd86db3445a23cfa | 201 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 155 | 194 | 9.9E-7 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/106096|m.23347 | UnnamedSample_HQ_transcript/106096 | Identity 0.904 too low. | e1287324c1b31409dd86db3445a23cfa | 201 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 155 | 194 | 9.9E-7 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/96914|m.22219 | UnnamedSample_HQ_transcript/96914 | Identity 0.914 too low. | e1287324c1b31409dd86db3445a23cfa | 201 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 155 | 194 | 9.9E-7 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/17576|m.6186 | UnnamedSample_HQ_transcript/17576 | Coverage 0.693 too low. | 8c6068fdc8e047f0ec268e4a785e3163 | 611 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 548 | 610 | 1.9E-9 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/17576|m.6186 | UnnamedSample_HQ_transcript/17576 | Coverage 0.693 too low. | 8c6068fdc8e047f0ec268e4a785e3163 | 611 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 130 | 397 | 1.4E-36 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/54298|m.14894 | UnnamedSample_HQ_transcript/54298 | Coverage 0.396 too low. | e3c2cbce132b9a8003f374f6d1594030 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 420 | 443 | 0.0081 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/54298|m.14894 | UnnamedSample_HQ_transcript/54298 | Coverage 0.396 too low. | e3c2cbce132b9a8003f374f6d1594030 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 391 | 412 | 1.5E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/54298|m.14894 | UnnamedSample_HQ_transcript/54298 | Coverage 0.396 too low. | e3c2cbce132b9a8003f374f6d1594030 | 449 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/47890|m.13556 | UnnamedSample_HQ_transcript/47890 | Coverage 0.875 too low. | ad9fb6c0ac52235458c94a135ea88101 | 658 | Pfam | PF03098 | Animal haem peroxidase | 145 | 657 | 2.9E-171 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/56550|m.15351 | UnnamedSample_HQ_transcript/56550 | Coverage 0.973 too low. | 5acf1d0169a882186fafd75aab0dd112 | 309 | Pfam | PF02781 | Glucose-6-phosphate dehydrogenase, C-terminal domain | 6 | 297 | 1.4E-116 | T | 22-09-2020 | IPR022675 | Glucose-6-phosphate dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/7687|m.3085 | UnnamedSample_HQ_transcript/7687 | Coverage 0.209 too low. | 8cafa7b96b5fd684146de9acf65c7124 | 1215 | Pfam | PF00567 | Tudor domain | 79 | 191 | 6.1E-23 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/7687|m.3085 | UnnamedSample_HQ_transcript/7687 | Coverage 0.209 too low. | 8cafa7b96b5fd684146de9acf65c7124 | 1215 | Pfam | PF00567 | Tudor domain | 1030 | 1138 | 1.4E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/10607|m.4025 | UnnamedSample_HQ_transcript/10607 | Coverage 0.442 too low. | 792b4c00bda1395d4b20292db7631394 | 934 | Pfam | PF00439 | Bromodomain | 119 | 199 | 3.6E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/15752|m.5627 | UnnamedSample_HQ_transcript/15752 | Unmapped. | 459fc7645144540c68068c99f4808361 | 1064 | Pfam | PF00910 | RNA helicase | 685 | 793 | 3.4E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/15752|m.5627 | UnnamedSample_HQ_transcript/15752 | Unmapped. | 459fc7645144540c68068c99f4808361 | 1064 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/21895|m.7397 | UnnamedSample_HQ_transcript/21895 | Coverage 0.187 too low. | 53875e8dca57aa9d75d9cc2de36cffa9 | 879 | Pfam | PF13927 | Immunoglobulin domain | 359 | 435 | 2.6E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21895|m.7397 | UnnamedSample_HQ_transcript/21895 | Coverage 0.187 too low. | 53875e8dca57aa9d75d9cc2de36cffa9 | 879 | Pfam | PF13895 | Immunoglobulin domain | 561 | 635 | 2.3E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/21895|m.7397 | UnnamedSample_HQ_transcript/21895 | Coverage 0.187 too low. | 53875e8dca57aa9d75d9cc2de36cffa9 | 879 | Pfam | PF07686 | Immunoglobulin V-set domain | 34 | 118 | 1.4E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/21895|m.7397 | UnnamedSample_HQ_transcript/21895 | Coverage 0.187 too low. | 53875e8dca57aa9d75d9cc2de36cffa9 | 879 | Pfam | PF00047 | Immunoglobulin domain | 163 | 240 | 2.6E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/21895|m.7397 | UnnamedSample_HQ_transcript/21895 | Coverage 0.187 too low. | 53875e8dca57aa9d75d9cc2de36cffa9 | 879 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 260 | 339 | 2.3E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/71693|m.18251 | UnnamedSample_HQ_transcript/71693 | Coverage 0.094 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/71693|m.18251 | UnnamedSample_HQ_transcript/71693 | Coverage 0.094 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/65398|m.17100 | UnnamedSample_HQ_transcript/65398 | Coverage 0.089 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/65398|m.17100 | UnnamedSample_HQ_transcript/65398 | Coverage 0.089 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/54402|m.14921 | UnnamedSample_HQ_transcript/54402 | Coverage 0.079 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/54402|m.14921 | UnnamedSample_HQ_transcript/54402 | Coverage 0.079 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/65012|m.17031 | UnnamedSample_HQ_transcript/65012 | Coverage 0.094 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/65012|m.17031 | UnnamedSample_HQ_transcript/65012 | Coverage 0.094 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/49536|m.13922 | UnnamedSample_HQ_transcript/49536 | Coverage 0.072 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/49536|m.13922 | UnnamedSample_HQ_transcript/49536 | Coverage 0.072 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/58441|m.15735 | UnnamedSample_HQ_transcript/58441 | Coverage 0.083 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/58441|m.15735 | UnnamedSample_HQ_transcript/58441 | Coverage 0.083 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/55613|m.15157 | UnnamedSample_HQ_transcript/55613 | Coverage 0.082 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/55613|m.15157 | UnnamedSample_HQ_transcript/55613 | Coverage 0.082 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/66712|m.17356 | UnnamedSample_HQ_transcript/66712 | Coverage 0.088 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/66712|m.17356 | UnnamedSample_HQ_transcript/66712 | Coverage 0.088 too low. | ca9c9d57f98dea7796abd5579a5ad104 | 450 | Pfam | PF00089 | Trypsin | 201 | 446 | 1.1E-45 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/94603|m.21891 | UnnamedSample_HQ_transcript/94603 | Coverage 0.949 too low. | c5f06a3df458cd3f88d6b49c5f8e0e11 | 365 | Pfam | PF00180 | Isocitrate/isopropylmalate dehydrogenase | 3 | 333 | 7.4E-67 | T | 22-09-2020 | IPR024084 | Isopropylmalate dehydrogenase-like domain |
| UnnamedSample_HQ_transcript/94324|m.21850 | UnnamedSample_HQ_transcript/94324 | Coverage 0.934 too low. | b89f27ef6d20775ded727a4635f0a495 | 337 | Pfam | PF00135 | Carboxylesterase family | 18 | 337 | 1.2E-111 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/120383|m.24873 | UnnamedSample_HQ_transcript/120383 | Coverage 0.989 too low. | da83485a8325bf85d08d7fdd6c371793 | 199 | Pfam | PF02005 | N2,N2-dimethylguanosine tRNA methyltransferase | 11 | 129 | 2.2E-34 | T | 22-09-2020 | IPR002905 | tRNA methyltransferase, Trm1 |
| UnnamedSample_HQ_transcript/22899|m.7665 | UnnamedSample_HQ_transcript/22899 | Coverage 0.119 too low. | 29764e4640bd046530538aa44f459a8f | 760 | Pfam | PF07679 | Immunoglobulin I-set domain | 23 | 103 | 2.5E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/22899|m.7665 | UnnamedSample_HQ_transcript/22899 | Coverage 0.119 too low. | 29764e4640bd046530538aa44f459a8f | 760 | Pfam | PF13927 | Immunoglobulin domain | 413 | 494 | 2.8E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/22899|m.7665 | UnnamedSample_HQ_transcript/22899 | Coverage 0.119 too low. | 29764e4640bd046530538aa44f459a8f | 760 | Pfam | PF13927 | Immunoglobulin domain | 250 | 312 | 2.0E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/22899|m.7665 | UnnamedSample_HQ_transcript/22899 | Coverage 0.119 too low. | 29764e4640bd046530538aa44f459a8f | 760 | Pfam | PF13927 | Immunoglobulin domain | 329 | 393 | 3.9E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/22899|m.7665 | UnnamedSample_HQ_transcript/22899 | Coverage 0.119 too low. | 29764e4640bd046530538aa44f459a8f | 760 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 129 | 218 | 6.1E-15 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/26648|m.8633 | UnnamedSample_HQ_transcript/26648 | Coverage 0.036 too low. | 77cd7638a1da9324ff00aea4be18a11f | 641 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 44 | 583 | 4.7E-185 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/61537|m.16356 | UnnamedSample_HQ_transcript/61537 | Coverage 0.947 too low. | 53b42e8714d54c0fae9e4e925aeca4dd | 568 | Pfam | PF17862 | AAA+ lid domain | 278 | 315 | 3.2E-13 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/61537|m.16356 | UnnamedSample_HQ_transcript/61537 | Coverage 0.947 too low. | 53b42e8714d54c0fae9e4e925aeca4dd | 568 | Pfam | PF01434 | Peptidase family M41 | 331 | 512 | 3.5E-66 | T | 22-09-2020 | IPR000642 | Peptidase M41 |
| UnnamedSample_HQ_transcript/61537|m.16356 | UnnamedSample_HQ_transcript/61537 | Coverage 0.947 too low. | 53b42e8714d54c0fae9e4e925aeca4dd | 568 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 116 | 247 | 1.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/118583|m.24734 | UnnamedSample_HQ_transcript/118583 | Coverage 0.984 too low. | 8c8dea54cc2053c0d1adc8dfbff87252 | 170 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 34 | 170 | 4.5E-30 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/3723|m.1702 | UnnamedSample_HQ_transcript/3723 | Unmapped. | fc2ebe209ac4fbd19a698a52de67ecdc | 1483 | Pfam | PF00910 | RNA helicase | 55 | 163 | 5.3E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/3723|m.1702 | UnnamedSample_HQ_transcript/3723 | Unmapped. | fc2ebe209ac4fbd19a698a52de67ecdc | 1483 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1117 | 1442 | 1.8E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/91733|m.21505 | UnnamedSample_HQ_transcript/91733 | Coverage 0.895 too low. | 47eb3b17c1a221adb4b09bbd0b8e9636 | 302 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 14 | 62 | 1.3E-12 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/51263|m.14295 | UnnamedSample_HQ_transcript/51263 | Coverage 0.281 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/63119|m.16658 | UnnamedSample_HQ_transcript/63119 | Coverage 0.322 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/28475|m.9085 | UnnamedSample_HQ_transcript/28475 | Coverage 0.213 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/27047|m.8727 | UnnamedSample_HQ_transcript/27047 | Coverage 0.209 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/5579|m.2381 | UnnamedSample_HQ_transcript/5579 | Coverage 0.871 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/18690|m.6493 | UnnamedSample_HQ_transcript/18690 | Coverage 0.183 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/36325|m.11016 | UnnamedSample_HQ_transcript/36325 | Coverage 0.127 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/58498|m.15746 | UnnamedSample_HQ_transcript/58498 | Coverage 0.304 too low. | 153e497793731844a2a395923f94077d | 409 | Pfam | PF00170 | bZIP transcription factor | 318 | 380 | 2.1E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 21 | 56 | 4.5E-8 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 104 | 140 | 6.6E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 146 | 203 | 3.1E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 62 | 98 | 6.4E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 207 | 245 | 2.2E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/88067|m.20950 | UnnamedSample_HQ_transcript/88067 | Coverage 0.725 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 250 | 286 | 3.0E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 21 | 56 | 4.5E-8 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 104 | 140 | 6.6E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 146 | 203 | 3.1E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 62 | 98 | 6.4E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 207 | 245 | 2.2E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65145|m.17056 | UnnamedSample_HQ_transcript/65145 | Coverage 0.800 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 250 | 286 | 3.0E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 21 | 56 | 4.5E-8 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 104 | 140 | 6.6E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 146 | 203 | 3.1E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 62 | 98 | 6.4E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 207 | 245 | 2.2E-10 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/100004|m.22631 | UnnamedSample_HQ_transcript/100004 | Coverage 0.900 too low. | 3f66c8e1de8f9a7aa6cc9ecfe5c4a9cc | 289 | Pfam | PF00400 | WD domain, G-beta repeat | 250 | 286 | 3.0E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/47836|m.13544 | UnnamedSample_HQ_transcript/47836 | Identity 0.828 too low. | d9223a81bf6e040eb324ab35e0ddfbe5 | 527 | Pfam | PF00617 | RasGEF domain | 227 | 439 | 5.4E-58 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/47836|m.13544 | UnnamedSample_HQ_transcript/47836 | Identity 0.828 too low. | d9223a81bf6e040eb324ab35e0ddfbe5 | 527 | Pfam | PF00618 | RasGEF N-terminal motif | 65 | 162 | 2.4E-19 | T | 22-09-2020 | IPR000651 | Ras-like guanine nucleotide exchange factor, N-terminal |
| UnnamedSample_HQ_transcript/12203|m.4558 | UnnamedSample_HQ_transcript/12203 | Coverage 0.915 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF00433 | Protein kinase C terminal domain | 980 | 1022 | 1.7E-10 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/12203|m.4558 | UnnamedSample_HQ_transcript/12203 | Coverage 0.915 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 257 | 319 | 5.3E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12203|m.4558 | UnnamedSample_HQ_transcript/12203 | Coverage 0.915 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 162 | 226 | 4.8E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12203|m.4558 | UnnamedSample_HQ_transcript/12203 | Coverage 0.915 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 44 | 100 | 2.3E-8 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12203|m.4558 | UnnamedSample_HQ_transcript/12203 | Coverage 0.915 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF00069 | Protein kinase domain | 700 | 958 | 5.4E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/16077|m.5735 | UnnamedSample_HQ_transcript/16077 | Coverage 0.902 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF00433 | Protein kinase C terminal domain | 980 | 1022 | 1.7E-10 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/16077|m.5735 | UnnamedSample_HQ_transcript/16077 | Coverage 0.902 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 257 | 319 | 5.3E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/16077|m.5735 | UnnamedSample_HQ_transcript/16077 | Coverage 0.902 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 162 | 226 | 4.8E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/16077|m.5735 | UnnamedSample_HQ_transcript/16077 | Coverage 0.902 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF02185 | Hr1 repeat | 44 | 100 | 2.3E-8 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/16077|m.5735 | UnnamedSample_HQ_transcript/16077 | Coverage 0.902 too low. | 54e41441ee503d302601c5d35ba0e964 | 1027 | Pfam | PF00069 | Protein kinase domain | 700 | 958 | 5.4E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/16238|m.5778 | UnnamedSample_HQ_transcript/16238 | Coverage 0.079 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06367 | Diaphanous FH3 Domain | 315 | 514 | 4.4E-45 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/16238|m.5778 | UnnamedSample_HQ_transcript/16238 | Coverage 0.079 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF02181 | Formin Homology 2 Domain | 608 | 987 | 1.5E-94 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/16238|m.5778 | UnnamedSample_HQ_transcript/16238 | Coverage 0.079 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 253 | 312 | 1.7E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/16238|m.5778 | UnnamedSample_HQ_transcript/16238 | Coverage 0.079 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 55 | 174 | 2.5E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/4276|m.1905 | UnnamedSample_HQ_transcript/4276 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06367 | Diaphanous FH3 Domain | 315 | 514 | 4.4E-45 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/4276|m.1905 | UnnamedSample_HQ_transcript/4276 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF02181 | Formin Homology 2 Domain | 608 | 987 | 1.5E-94 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/4276|m.1905 | UnnamedSample_HQ_transcript/4276 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 253 | 312 | 1.7E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/4276|m.1905 | UnnamedSample_HQ_transcript/4276 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 55 | 174 | 2.5E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/11462|m.4314 | UnnamedSample_HQ_transcript/11462 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06367 | Diaphanous FH3 Domain | 315 | 514 | 4.4E-45 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/11462|m.4314 | UnnamedSample_HQ_transcript/11462 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF02181 | Formin Homology 2 Domain | 608 | 987 | 1.5E-94 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/11462|m.4314 | UnnamedSample_HQ_transcript/11462 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 253 | 312 | 1.7E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/11462|m.4314 | UnnamedSample_HQ_transcript/11462 | Coverage 0.110 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 55 | 174 | 2.5E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/4607|m.2039 | UnnamedSample_HQ_transcript/4607 | Coverage 0.085 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06367 | Diaphanous FH3 Domain | 315 | 514 | 4.4E-45 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/4607|m.2039 | UnnamedSample_HQ_transcript/4607 | Coverage 0.085 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF02181 | Formin Homology 2 Domain | 608 | 987 | 1.5E-94 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/4607|m.2039 | UnnamedSample_HQ_transcript/4607 | Coverage 0.085 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 253 | 312 | 1.7E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/4607|m.2039 | UnnamedSample_HQ_transcript/4607 | Coverage 0.085 too low. | b2dc938ddd135a0112d1dfdabc81064f | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 55 | 174 | 2.5E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/36859|m.11133 | UnnamedSample_HQ_transcript/36859 | Unmapped. | 9baedba0874308960e435b3ec015fe15 | 513 | Pfam | PF04760 | Translation initiation factor IF-2, N-terminal region | 163 | 213 | 8.5E-14 | T | 22-09-2020 | IPR006847 | Translation initiation factor IF-2, N-terminal |
| UnnamedSample_HQ_transcript/36859|m.11133 | UnnamedSample_HQ_transcript/36859 | Unmapped. | 9baedba0874308960e435b3ec015fe15 | 513 | Pfam | PF00009 | Elongation factor Tu GTP binding domain | 244 | 401 | 3.4E-33 | T | 22-09-2020 | IPR000795 | Transcription factor, GTP-binding domain |
| UnnamedSample_HQ_transcript/34768|m.10665 | UnnamedSample_HQ_transcript/34768 | Coverage 0.894 too low. | 93f09f3fa3742742e40d856253769561 | 281 | Pfam | PF02214 | BTB/POZ domain | 39 | 127 | 3.4E-17 | T | 22-09-2020 | IPR003131 | Potassium channel tetramerisation-type BTB domain |
| UnnamedSample_HQ_transcript/21183|m.7195 | UnnamedSample_HQ_transcript/21183 | Coverage 0.263 too low. | 93f09f3fa3742742e40d856253769561 | 281 | Pfam | PF02214 | BTB/POZ domain | 39 | 127 | 3.4E-17 | T | 22-09-2020 | IPR003131 | Potassium channel tetramerisation-type BTB domain |
| UnnamedSample_HQ_transcript/35510|m.10819 | UnnamedSample_HQ_transcript/35510 | Coverage 0.102 too low. | 93f09f3fa3742742e40d856253769561 | 281 | Pfam | PF02214 | BTB/POZ domain | 39 | 127 | 3.4E-17 | T | 22-09-2020 | IPR003131 | Potassium channel tetramerisation-type BTB domain |
| UnnamedSample_HQ_transcript/70920|m.18093 | UnnamedSample_HQ_transcript/70920 | Coverage 0.252 too low. | 97644c7956e960b8eb2aadb9438f49bc | 446 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/70920|m.18093 | UnnamedSample_HQ_transcript/70920 | Coverage 0.252 too low. | 97644c7956e960b8eb2aadb9438f49bc | 446 | Pfam | PF00096 | Zinc finger, C2H2 type | 418 | 441 | 1.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/70920|m.18093 | UnnamedSample_HQ_transcript/70920 | Coverage 0.252 too low. | 97644c7956e960b8eb2aadb9438f49bc | 446 | Pfam | PF00096 | Zinc finger, C2H2 type | 389 | 409 | 0.0012 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/63263|m.16682 | UnnamedSample_HQ_transcript/63263 | Coverage 0.236 too low. | 14a91c791fe9746df97fbee54a8c1eb4 | 620 | Pfam | PF02181 | Formin Homology 2 Domain | 1 | 246 | 6.5E-60 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/87144|m.20816 | UnnamedSample_HQ_transcript/87144 | Coverage 0.973 too low. | db46a91938dfa15cfaf06d863f347a5b | 342 | Pfam | PF09298 | Fumarylacetoacetase N-terminal | 1 | 43 | 4.5E-6 | T | 22-09-2020 | IPR015377 | Fumarylacetoacetase, N-terminal |
| UnnamedSample_HQ_transcript/87144|m.20816 | UnnamedSample_HQ_transcript/87144 | Coverage 0.973 too low. | db46a91938dfa15cfaf06d863f347a5b | 342 | Pfam | PF01557 | Fumarylacetoacetate (FAA) hydrolase family | 57 | 334 | 7.8E-49 | T | 22-09-2020 | IPR011234 | Fumarylacetoacetase-like, C-terminal |
| UnnamedSample_HQ_transcript/120154|m.24855 | UnnamedSample_HQ_transcript/120154 | Coverage 0.977 too low. | d0975bfa8644d988a92a98dad85611d6 | 110 | Pfam | PF12352 | Snare region anchored in the vesicle membrane C-terminus | 15 | 74 | 1.0E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/116413|m.24528 | UnnamedSample_HQ_transcript/116413 | Coverage 0.802 too low. | d0975bfa8644d988a92a98dad85611d6 | 110 | Pfam | PF12352 | Snare region anchored in the vesicle membrane C-terminus | 15 | 74 | 1.0E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2042|m.1075 | UnnamedSample_HQ_transcript/2042 | Coverage 0.111 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00784 | MyTH4 domain | 178 | 256 | 6.4E-21 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/2042|m.1075 | UnnamedSample_HQ_transcript/2042 | Coverage 0.111 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00784 | MyTH4 domain | 101 | 151 | 5.6E-7 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/2042|m.1075 | UnnamedSample_HQ_transcript/2042 | Coverage 0.111 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00373 | FERM central domain | 374 | 504 | 1.1E-15 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/3158|m.1507 | UnnamedSample_HQ_transcript/3158 | Coverage 0.445 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00784 | MyTH4 domain | 178 | 256 | 6.4E-21 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/3158|m.1507 | UnnamedSample_HQ_transcript/3158 | Coverage 0.445 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00784 | MyTH4 domain | 101 | 151 | 5.6E-7 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/3158|m.1507 | UnnamedSample_HQ_transcript/3158 | Coverage 0.445 too low. | 8d9af64b5f525254b305a3c24052857d | 637 | Pfam | PF00373 | FERM central domain | 374 | 504 | 1.1E-15 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/68491|m.17666 | UnnamedSample_HQ_transcript/68491 | Coverage 0.961 too low. | 91fd4ecd667418258e2cc8a913c2fe41 | 580 | Pfam | PF00435 | Spectrin repeat | 469 | 577 | 5.9E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/68491|m.17666 | UnnamedSample_HQ_transcript/68491 | Coverage 0.961 too low. | 91fd4ecd667418258e2cc8a913c2fe41 | 580 | Pfam | PF00435 | Spectrin repeat | 352 | 457 | 1.9E-23 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/68491|m.17666 | UnnamedSample_HQ_transcript/68491 | Coverage 0.961 too low. | 91fd4ecd667418258e2cc8a913c2fe41 | 580 | Pfam | PF00435 | Spectrin repeat | 233 | 340 | 3.6E-13 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/68491|m.17666 | UnnamedSample_HQ_transcript/68491 | Coverage 0.961 too low. | 91fd4ecd667418258e2cc8a913c2fe41 | 580 | Pfam | PF00307 | Calponin homology (CH) domain | 6 | 93 | 1.0E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/68491|m.17666 | UnnamedSample_HQ_transcript/68491 | Coverage 0.961 too low. | 91fd4ecd667418258e2cc8a913c2fe41 | 580 | Pfam | PF00307 | Calponin homology (CH) domain | 103 | 208 | 6.8E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/41333|m.12124 | UnnamedSample_HQ_transcript/41333 | Coverage 0.564 too low. | 03d4ea6e2e45180193a99e4d67c4aca7 | 662 | Pfam | PF00595 | PDZ domain | 372 | 443 | 2.3E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/41333|m.12124 | UnnamedSample_HQ_transcript/41333 | Coverage 0.564 too low. | 03d4ea6e2e45180193a99e4d67c4aca7 | 662 | Pfam | PF00595 | PDZ domain | 554 | 635 | 7.6E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/45423|m.13011 | UnnamedSample_HQ_transcript/45423 | Coverage 0.544 too low. | 03d4ea6e2e45180193a99e4d67c4aca7 | 662 | Pfam | PF00595 | PDZ domain | 372 | 443 | 2.3E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/45423|m.13011 | UnnamedSample_HQ_transcript/45423 | Coverage 0.544 too low. | 03d4ea6e2e45180193a99e4d67c4aca7 | 662 | Pfam | PF00595 | PDZ domain | 554 | 635 | 7.6E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/114388|m.24331 | UnnamedSample_HQ_transcript/114388 | Identity 0.662 too low. | dc472654268008c741e291a18dbd8778 | 193 | Pfam | PF03332 | Eukaryotic phosphomannomutase | 8 | 191 | 6.6E-92 | T | 22-09-2020 | IPR005002 | Phosphomannomutase |
| UnnamedSample_HQ_transcript/16731|m.5927 | UnnamedSample_HQ_transcript/16731 | Coverage 0.866 too low. | 3910d492365d6c7768a0d136fdc2255c | 353 | Pfam | PF07346 | Protein of unknown function (DUF1477) | 239 | 272 | 1.8E-4 | T | 22-09-2020 | IPR009946 | Autographa californica nuclear polyhedrosis virus (AcMNPV), Orf19 |
| UnnamedSample_HQ_transcript/38738|m.11565 | UnnamedSample_HQ_transcript/38738 | Coverage 0.734 too low. | 72167824f699952987d3a877703681b5 | 458 | Pfam | PF00096 | Zinc finger, C2H2 type | 287 | 310 | 0.0019 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/38738|m.11565 | UnnamedSample_HQ_transcript/38738 | Coverage 0.734 too low. | 72167824f699952987d3a877703681b5 | 458 | Pfam | PF00096 | Zinc finger, C2H2 type | 238 | 260 | 1.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/41063|m.12076 | UnnamedSample_HQ_transcript/41063 | Coverage 0.827 too low. | 3b93beb70ecf99fcf5f08e3cb100e713 | 674 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 28 | 673 | 1.6E-245 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/41697|m.12200 | UnnamedSample_HQ_transcript/41697 | Coverage 0.777 too low. | 8f3cc9438092e5d2b9cc7025668b9dc1 | 592 | Pfam | PF12832 | MFS_1 like family | 8 | 536 | 2.9E-67 | T | 22-09-2020 | IPR024989 | Major facilitator superfamily associated domain |
| UnnamedSample_HQ_transcript/19015|m.6585 | UnnamedSample_HQ_transcript/19015 | Coverage 0.740 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF15410 | Pleckstrin homology domain | 54 | 156 | 8.7E-13 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/19015|m.6585 | UnnamedSample_HQ_transcript/19015 | Coverage 0.740 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF00620 | RhoGAP domain | 274 | 424 | 1.6E-47 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/48790|m.13758 | UnnamedSample_HQ_transcript/48790 | Coverage 0.853 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF15410 | Pleckstrin homology domain | 54 | 156 | 8.7E-13 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/48790|m.13758 | UnnamedSample_HQ_transcript/48790 | Coverage 0.853 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF00620 | RhoGAP domain | 274 | 424 | 1.6E-47 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/12316|m.4596 | UnnamedSample_HQ_transcript/12316 | Coverage 0.677 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF15410 | Pleckstrin homology domain | 54 | 156 | 8.7E-13 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/12316|m.4596 | UnnamedSample_HQ_transcript/12316 | Coverage 0.677 too low. | 2854e94be73583656f0498a0aac55117 | 655 | Pfam | PF00620 | RhoGAP domain | 274 | 424 | 1.6E-47 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/10331|m.3934 | UnnamedSample_HQ_transcript/10331 | Coverage 0.202 too low. | f55ed636a6380b3199a7194685f386c1 | 1115 | Pfam | PF07647 | SAM domain (Sterile alpha motif) | 1026 | 1093 | 2.3E-7 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/10331|m.3934 | UnnamedSample_HQ_transcript/10331 | Coverage 0.202 too low. | f55ed636a6380b3199a7194685f386c1 | 1115 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 942 | 1003 | 6.8E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/13892|m.5078 | UnnamedSample_HQ_transcript/13892 | Coverage 0.978 too low. | cc324ee2f261561895e830509ecc6b71 | 291 | Pfam | PF02781 | Glucose-6-phosphate dehydrogenase, C-terminal domain | 6 | 271 | 5.4E-109 | T | 22-09-2020 | IPR022675 | Glucose-6-phosphate dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/27985|m.8965 | UnnamedSample_HQ_transcript/27985 | Coverage 0.687 too low. | 0b0bcb00dd23888f5c38bd03342f08c3 | 526 | Pfam | PF02145 | Rap/ran-GAP | 93 | 273 | 3.1E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/102797|m.22970 | UnnamedSample_HQ_transcript/102797 | Coverage 0.904 too low. | 4a4b5624ce8f5a0b52d68e844957fec9 | 314 | Pfam | PF13339 | Apoptosis antagonizing transcription factor | 211 | 299 | 8.0E-19 | T | 22-09-2020 | IPR025160 | AATF leucine zipper-containing domain |
| UnnamedSample_HQ_transcript/16954|m.5990 | UnnamedSample_HQ_transcript/16954 | Unmapped. | 17e0096f1b723284c5328204ea55bc96 | 671 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 1.4E-6 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/25276|m.8282 | UnnamedSample_HQ_transcript/25276 | Unmapped. | 17e0096f1b723284c5328204ea55bc96 | 671 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 1.4E-6 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/24879|m.8190 | UnnamedSample_HQ_transcript/24879 | Coverage 0.941 too low. | 7c117c3d6ea0408cccaf7aaaa1dbe6dd | 435 | Pfam | PF02793 | Hormone receptor domain | 34 | 98 | 9.1E-13 | T | 22-09-2020 | IPR001879 | GPCR, family 2, extracellular hormone receptor domain |
| UnnamedSample_HQ_transcript/24879|m.8190 | UnnamedSample_HQ_transcript/24879 | Coverage 0.941 too low. | 7c117c3d6ea0408cccaf7aaaa1dbe6dd | 435 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 109 | 386 | 4.5E-54 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/24825|m.8174 | UnnamedSample_HQ_transcript/24825 | Coverage 0.084 too low. | 092480129574ed900e8dde306348dfb0 | 825 | Pfam | PF01426 | BAH domain | 675 | 821 | 1.0E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/23101|m.7716 | UnnamedSample_HQ_transcript/23101 | Coverage 0.105 too low. | 092480129574ed900e8dde306348dfb0 | 825 | Pfam | PF01426 | BAH domain | 675 | 821 | 1.0E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/28378|m.9064 | UnnamedSample_HQ_transcript/28378 | Coverage 0.036 too low. | 092480129574ed900e8dde306348dfb0 | 825 | Pfam | PF01426 | BAH domain | 675 | 821 | 1.0E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/3512|m.1619 | UnnamedSample_HQ_transcript/3512 | Coverage 0.923 too low. | 2eb286e8b3fb3cbf57a28b8deb28ba7d | 1480 | Pfam | PF01429 | Methyl-CpG binding domain | 469 | 531 | 1.4E-7 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/3020|m.1455 | UnnamedSample_HQ_transcript/3020 | Coverage 0.930 too low. | 2eb286e8b3fb3cbf57a28b8deb28ba7d | 1480 | Pfam | PF01429 | Methyl-CpG binding domain | 469 | 531 | 1.4E-7 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/84470|m.20409 | UnnamedSample_HQ_transcript/84470 | Coverage 0.139 too low. | ac1e64e8b557e8d3f18344cc9d93c731 | 340 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 50 | 340 | 3.0E-21 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/85278|m.20544 | UnnamedSample_HQ_transcript/85278 | Coverage 0.140 too low. | ac1e64e8b557e8d3f18344cc9d93c731 | 340 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 50 | 340 | 3.0E-21 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/93646|m.21757 | UnnamedSample_HQ_transcript/93646 | Identity 0.947 too low. | aceaa6605a10282bb5bfa60fc8c3c59a | 341 | Pfam | PF00226 | DnaJ domain | 277 | 332 | 1.2E-11 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/93646|m.21757 | UnnamedSample_HQ_transcript/93646 | Identity 0.947 too low. | aceaa6605a10282bb5bfa60fc8c3c59a | 341 | Pfam | PF00012 | Hsp70 protein | 3 | 264 | 5.7E-66 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/24598|m.8103 | UnnamedSample_HQ_transcript/24598 | Coverage 0.924 too low. | 3ac9ec1eb3e8f98798a1894e2e26298f | 341 | Pfam | PF00271 | Helicase conserved C-terminal domain | 250 | 328 | 1.9E-14 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/24598|m.8103 | UnnamedSample_HQ_transcript/24598 | Coverage 0.924 too low. | 3ac9ec1eb3e8f98798a1894e2e26298f | 341 | Pfam | PF00270 | DEAD/DEAH box helicase | 41 | 212 | 1.3E-48 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/41045|m.12071 | UnnamedSample_HQ_transcript/41045 | Coverage 0.214 too low. | 39c0fe34a4d0ec3ba0115b284426ecbb | 265 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 37 | 102 | 9.2E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/2608|m.1279 | UnnamedSample_HQ_transcript/2608 | Coverage 0.055 too low. | 15ff894ff7c5254c46af4e43e077869d | 1624 | Pfam | PF14598 | PAS domain | 307 | 416 | 1.3E-31 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2291|m.1168 | UnnamedSample_HQ_transcript/2291 | Coverage 0.061 too low. | 15ff894ff7c5254c46af4e43e077869d | 1624 | Pfam | PF14598 | PAS domain | 307 | 416 | 1.3E-31 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/82077|m.20041 | UnnamedSample_HQ_transcript/82077 | Coverage 0.391 too low. | f1f905b6615fc1cc64ba6dce72a56aa3 | 468 | Pfam | PF00155 | Aminotransferase class I and II | 156 | 460 | 3.5E-31 | T | 22-09-2020 | IPR004839 | Aminotransferase, class I/classII |
| UnnamedSample_HQ_transcript/83963|m.20333 | UnnamedSample_HQ_transcript/83963 | Coverage 0.190 too low. | f82c307ce0ae9b5937c2e6055e3a0f51 | 421 | Pfam | PF04227 | Indigoidine synthase A like protein | 19 | 309 | 1.8E-124 | T | 22-09-2020 | IPR007342 | Pseudouridine-5'-phosphate glycosidase |
| UnnamedSample_HQ_transcript/45723|m.13081 | UnnamedSample_HQ_transcript/45723 | Coverage 0.962 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF08373 | RAP domain | 469 | 517 | 2.6E-6 | T | 22-09-2020 | IPR013584 | RAP domain |
| UnnamedSample_HQ_transcript/45723|m.13081 | UnnamedSample_HQ_transcript/45723 | Coverage 0.962 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF08368 | FAST kinase-like protein, subdomain 2 | 361 | 445 | 7.9E-13 | T | 22-09-2020 | IPR013579 | FAST kinase-like protein, subdomain 2 |
| UnnamedSample_HQ_transcript/45723|m.13081 | UnnamedSample_HQ_transcript/45723 | Coverage 0.962 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF06743 | FAST kinase-like protein, subdomain 1 | 281 | 347 | 1.6E-13 | T | 22-09-2020 | IPR010622 | FAST kinase leucine-rich |
| UnnamedSample_HQ_transcript/47319|m.13431 | UnnamedSample_HQ_transcript/47319 | Coverage 0.947 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF08373 | RAP domain | 469 | 517 | 2.6E-6 | T | 22-09-2020 | IPR013584 | RAP domain |
| UnnamedSample_HQ_transcript/47319|m.13431 | UnnamedSample_HQ_transcript/47319 | Coverage 0.947 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF08368 | FAST kinase-like protein, subdomain 2 | 361 | 445 | 7.9E-13 | T | 22-09-2020 | IPR013579 | FAST kinase-like protein, subdomain 2 |
| UnnamedSample_HQ_transcript/47319|m.13431 | UnnamedSample_HQ_transcript/47319 | Coverage 0.947 too low. | 911f7eb6b39d8fc387e906097b2ccb3e | 526 | Pfam | PF06743 | FAST kinase-like protein, subdomain 1 | 281 | 347 | 1.6E-13 | T | 22-09-2020 | IPR010622 | FAST kinase leucine-rich |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 159 | 367 | 5.8E-78 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02436 | Conserved carboxylase domain | 886 | 1084 | 7.0E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 383 | 491 | 2.9E-31 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00682 | HMGL-like | 590 | 860 | 1.0E-27 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00289 | Biotin carboxylase, N-terminal domain | 45 | 152 | 4.7E-41 | T | 22-09-2020 | IPR005481 | Biotin carboxylase-like, N-terminal domain |
| UnnamedSample_HQ_transcript/7873|m.3142 | UnnamedSample_HQ_transcript/7873 | Coverage 0.968 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00364 | Biotin-requiring enzyme | 1135 | 1202 | 2.2E-18 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 159 | 367 | 5.8E-78 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02436 | Conserved carboxylase domain | 886 | 1084 | 7.0E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 383 | 491 | 2.9E-31 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00682 | HMGL-like | 590 | 860 | 1.0E-27 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00289 | Biotin carboxylase, N-terminal domain | 45 | 152 | 4.7E-41 | T | 22-09-2020 | IPR005481 | Biotin carboxylase-like, N-terminal domain |
| UnnamedSample_HQ_transcript/7038|m.2874 | UnnamedSample_HQ_transcript/7038 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00364 | Biotin-requiring enzyme | 1135 | 1202 | 2.2E-18 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/6387|m.2667 | UnnamedSample_HQ_transcript/6387 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 159 | 367 | 5.8E-78 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/6387|m.2667 | UnnamedSample_HQ_transcript/6387 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02436 | Conserved carboxylase domain | 886 | 1084 | 7.0E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/6387|m.2667 | UnnamedSample_HQ_transcript/6387 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 383 | 491 | 2.9E-31 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/6387|m.2667 | UnnamedSample_HQ_transcript/6387 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00682 | HMGL-like | 590 | 860 | 1.0E-27 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/6387|m.2667 | UnnamedSample_HQ_transcript/6387 | Coverage 0.938 too low. | 9e088e206217230fad8b2ded9ca89a1b | 1203 | Pfam | PF00289 | Biotin carboxylase, N-terminal domain | 45 | 152 | 4.7E-41 | T | 22-09-2020 | IPR005481 | Biotin carboxylase-like, N-terminal domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
